Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats

Anesthesia and Analgesia

Volumn 86, Issue 4, 1998, Pages 825-829

  Plesan, Aida ^a   Hedman, Ulrika ^a   Xu, Xiao Jun ^a   Wiesenfeld Hallin, Zsuzsanna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; HOT PLATE TEST; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; ANIMALS; ANTITUSSIVE AGENTS; CONSCIOUSNESS; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DYSKINESIA, DRUG-INDUCED; EXCITATORY AMINO ACID ANTAGONISTS; HYPNOTICS AND SEDATIVES; INJECTIONS, SUBCUTANEOUS; KETAMINE; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 0031967754     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199804000-00027     Document Type: Article

References (25)

1. Lipton SA. Prospects for clinically tolerated NMDA antagonists: open blockers and alternative redox states of nitric oxide. Trends Neurosci 1993;16:527-33.
2. Sukiennik AW, Kream RM. N-methyl-D-aspartate receptors and pain. Curr Opin Anaesthesiol 1995;8:445-9.
3. Dickenson AH. NMDA receptor antagonists as analgesics. In: Fields HL, Liebeskind JC, eds. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Progress in pain research and management, vol 1. Seattle: IASP Press, 1994:173-87.
4. Coderre T, van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgetic agents: comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 1994; 59:345-52.
5. Eisenberg E, La Cross S, Strassman AM. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci Lett 1995;187:17-20.
6. Hao J-X, Xu X-J. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists. Pain 1996;66: 279-85.
7. Tal M, Bennett GJ. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci Lett 1993;151:107-10.
8. Hoffmann O, Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception, but does not reverse morphine tolerance in rats. Neuroreport 1996;7:838-40.
9. Grass S, Hoffmann O, Xu X-J, et al. Potentiation of morphine's antinociceptive effect by NMDA receptor antagonists in the rat. Acta Physiol Scand 1996;158:269-73.
10. Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 1992;135:67-70.
11. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992;573:321-3.
12. Wiesenfeld-Hallin Z, Hoffmann O. The effects of the cholecystokinin-B receptor antagonist CI 988 and the N-methyl-D-aspartate receptor antagonist dextromethorphan on the reversal of morphine tolerance in rats. Analgesia 1995;1:834-7.
13. Advokat C, Rhein FQ. Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan. Brain Res 1995;699:157-60.
14. Nichols ML, Lopez Y, Ossipov MH, et al. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphine A(1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain 1997;69:317-22.
15. Tortella FC, Pellicano M, Bowery NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 1989;10:501-7.
16. Edwards ND, Fletcher A, Cole JR, et al. Combined infusion of morphine and ketamine for postoperative pain in elderly patients. Anaesthesia 1993;48:124-7.
17. Parkhouse J, Marriott G. Postoperative analgesia with ketamine and pethidine. Anaesthesia 1977;32:285-9.
18. Javery KB, Ussert TW, Steger HG, et al. Comparison of morphine and morphine with ketamine for postoperative analgesia. Can J Anaesth 1996;43:212-5.
19. Bristow A, Orlikowski C. Subcutaneous ketamine analgesia: postoperative analgesia using subcutaneous infusions of ketamine and morphine. Ann R Coll Surg Engl 1989;71:64-6.
20. Yang C-Y, Wong C-S, Chang, J-Y, et al. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996;43:379-83.
21. Cherry DA, Plummer JL, Gourlay GK, et al. Ketamine as an adjunct to morphine in the treatment of pain. Pain 1995;62: 119-21.
22. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996;77:441-4.
23. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies: what advantages do they offer for the control of pain syndromes? Drugs 1998;55:1-4.
24. Ziegelgänsberger W, Tölle TR. The pharmacology of pain signalling. Curr Opin Neurobiol 1993;3:611-8.
25. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995;62:259-74.